Literature DB >> 7828853

CPSF recognition of an HIV-1 mRNA 3'-processing enhancer: multiple sequence contacts involved in poly(A) site definition.

G M Gilmartin1, E S Fleming, J Oetjen, B R Graveley.   

Abstract

The endonucleolytic cleavage and polyadenylation of a pre-mRNA in mammalian cells requires two cis-acting elements, a highly conserved AAUAAA hexamer and an amorphous U- or GU-rich downstream element, that together constitute the "core" poly(A) site. The terminal redundancy of the HIV-1 pre-mRNA requires that the processing machinery disregard a core poly(A) site at the 5' end of the transcript, and efficiently utilize an identical signal that resides near the 3' end. Efficient processing at the 3' core poly(A) site, both in vivo and in vitro, has been shown to require sequences 76 nucleotides upstream of the AAUAAA hexamer. In this report we demonstrate that this HIV-1 upstream element interacts directly with the 160-kD subunit of CPSF (cleavage polyadenylation specificity factor), the factor responsible for the recognition of the AAUAAA hexamer. The presence of the upstream element in the context of the AAUAAA hexamer directs the stable binding of CPSF to the pre-mRNA and enhances the efficiency of poly(A) addition in reactions reconstituted with purified CPSF and recombinant poly(A) polymerase. Our results indicate that the dependence of HIV-1 3' processing on upstream sequences is a consequence of the suboptimal sequence context of the AAUAAA hexamer. We suggest that poly(A) site definition involves the recognition of multiple heterogeneous sequence elements in the context of the AAUAAA hexamer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7828853     DOI: 10.1101/gad.9.1.72

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  65 in total

1.  Recruitment of a basal polyadenylation factor by the upstream sequence element of the human lamin B2 polyadenylation signal.

Authors:  S Brackenridge; N J Proudfoot
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  Stem-loop 1 of the U1 snRNP plays a critical role in the suppression of HIV-1 polyadenylation.

Authors:  M P Ashe; A Furger; N J Proudfoot
Journal:  RNA       Date:  2000-02       Impact factor: 4.942

Review 3.  Cytoplasmic polyadenylation in development and beyond.

Authors:  J D Richter
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

Review 4.  Formation of mRNA 3' ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis.

Authors:  J Zhao; L Hyman; C Moore
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

5.  An interaction between an Arabidopsis poly(A) polymerase and a homologue of the 100 kDa subunit of CPSF.

Authors:  Barbara J Elliott; Tomal Dattaroy; Lisa R Meeks-Midkiff; Kevin P Forbes; Arthur G Hunt
Journal:  Plant Mol Biol       Date:  2003-02       Impact factor: 4.076

Review 6.  Transcriptional and posttranscriptional regulation of HIV-1 gene expression.

Authors:  Jonathan Karn; C Martin Stoltzfus
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

7.  The poly A polymerase Star-PAP controls 3'-end cleavage by promoting CPSF interaction and specificity toward the pre-mRNA.

Authors:  Rakesh S Laishram; Richard A Anderson
Journal:  EMBO J       Date:  2010-11-19       Impact factor: 11.598

8.  A Kaposi's sarcoma virus RNA element that increases the nuclear abundance of intronless transcripts.

Authors:  Nicholas K Conrad; Joan A Steitz
Journal:  EMBO J       Date:  2005-04-28       Impact factor: 11.598

9.  Analysis of a noncanonical poly(A) site reveals a tripartite mechanism for vertebrate poly(A) site recognition.

Authors:  Krishnan Venkataraman; Kirk M Brown; Gregory M Gilmartin
Journal:  Genes Dev       Date:  2005-06-01       Impact factor: 11.361

10.  The upstream sequence element of the C2 complement poly(A) signal activates mRNA 3' end formation by two distinct mechanisms.

Authors:  A Moreira; Y Takagaki; S Brackenridge; M Wollerton; J L Manley; N J Proudfoot
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.